AβO is considered a primary pathological agent in early stages of AD preceding Aβ fibril formation 62, and the respective influences on microglia state by AβO and Aβ fibril may represent different neuroinflammation phases in AD. This evidence concerns the gene ABO and Alzheimer disease.